Atherosclerotic renovascular disease among hypertensive adults

Journal of Vascular Surgery

Volumn 50, Issue 3, 2009, Pages

  Davis, Ross P ^a   Pearce, Jeffrey D ^a   Craven, Timothy E ^a   Moore, Phillip S ^a   Edwards, Matthew S ^a   Godshall, Christopher J ^a   Hansen, Kimberley J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL ARTERY; RENOVASCULAR DISEASE;

EID: 68849118425     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.03.062     Document Type: Article

References (29)

1. Centers for Medicare and Medicaid Services, MedCAC Meetings. Percutaneous transluminal angioplasty (PTA) and stenting of the renal arteries. Centers for Medicare and Medicaid Services. http://www.cms.hhs.gov/mcd/viewmcac.asp?where = index&mid = 39 Accessed July 18, 2007.
2. Bax L., Mali W.P., Buskens E., Koomans H.A., Beutler J.J., Braam B., et al. The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. J Nephrol 16 (2003) 807-812
3. Tobe S.W., Atri M., Perkins N., Pugash R., and Bell C.M. Renal atherosclerotic revascularization evaluation study (RAVE study): study protocol of a randomized trial [NCT00127738]. BMC Nephrol 8 (2007) 4
4. Mistry S., Ives N., Harding J., Fitzpatrick-Ellis K., Lipkin G., Kalra P.A., et al. Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens 21 (2007) 511-515
5. Scarpioni R., Michieletti E., Cristinelli L., Ugolotti U., Scolari F., Venturelli C., et al. Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). J Nephrol 18 (2005) 423-428
6. Cooper C.J., Murphy T.P., Matsumoto A., Steffes M., Cohen D.J., Jaff M., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 152 (2006) 59-66
7. Axelrod D.A., Fendrick A.M., Carlos R.C., Lederman R.J., Froehlich J.B., Weder A.B., et al. Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits. J Endovasc Ther 10 (2003) 546-556
8. Dean R.H., and Hansen K.J. Prophylactic renal revascularization: has it a role?. In: Veith F. (Ed). Current critical problems in vascular surgery Vol 3 (1991), Quality Medical Publishing, Inc, St Louis 302-305
9. Pearce J.D., Craven B.L., Craven T.E., Piercy K.T., Stafford J.M., Edwards M.S., and Hansen K.J. Progression of atherosclerotic renovascular disease: a prospective population-based study. J Vasc Surg 44 (2006) 955-962 discussion 962-3
10. Levey A.S., Coresh J., Balk E., Kausz A.J., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
11. Hansen K.J., Edwards M.S., Craven T.E., Cherr G.S., Jackson S.A., Appel R.G., et al. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36 (2002) 443-451
12. Hansen K.J., Tribble R.W., Reavis S.W., Canzanello V.J., Craven T.E., Plonk G.W., and Dean R.H. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg 12 (1990) 227-236
13. Motew S.J., Cherr G.S., Craven T.E., Travis J.A., Wong J.M., Reavis S.W., and Hansen K.J. Renal duplex sonography: main renal artery versus hilar analysis. J Vasc Surg 32 (2000) 462-469 discussion 469-71
14. Laird N.M., and Ware J.H. Random-effects models for longitudinal data. Biometrics 38 (1982) 963-974
15. Wolfinger R.D. Heterogeneous variance-covariance structures for repeated measures. J Agr Biol Envir St 1 (1996) 205-230
16. Liang K.Y., and Zeger S.L. Longitudinal data analysis using generalized linear models. Biometrika 73 (1986) 13-22
17. Pillay W.R., Kan Y.M., Crinnion J.N., Wolfe J.H., and Joint Vascular Research Group U.K. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Br J Surg 89 (2002) 737-740
18. Zierler R.E., Bergelin R.O., Davidson R.C., Cantwell-Gab K., Polissar N.L., and Strandness Jr. D.E. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens 9 (1996) 1055-1061
19. Zierler R.E., Bergelin R.O., Isaacson J.A., and Strandness Jr. D.E. Natural history of atherosclerotic renal artery stenosis: a prospective study with duplex ultrasonography. J Vasc Surg 19 (1994) 250-257 discussion 257-8
20. Caps M.T., Zierler R.E., Polissar N.L., Bergelin R.O., Beach K.W., Cantwell-Gab K., et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 53 (1998) 735-742
21. Caps M.T., Perissinotto C., Zierler R.E., Polissar N.L., Bergelin R.O., Tullis M.J., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998) 2866-2872
22. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
23. Edwards M.S., Hansen K.J., Craven T.E., Cherr G.S., Bleyer A.J., Burke G.L., and Dean R.H. Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study. Am J Kidney Dis 41 (2003) 990-996
24. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., and Hansen K.J. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 165 (2005) 207-213
25. Cherr G.S., Hansen K.J., Craven T.E., Edwards M.S., Ligush Jr. J., Levy P.J., et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 35 (2002) 236-245
26. Hansen K.J., Cherr G.S., Craven T.E., Motew S.J., Travis J.A., Wong J.M., et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg 32 (2000) 472-481 discussion 481-2
27. O'Neil E.A., Hansen K.J., Canzanello V.J., Pennell T.C., and Dean R.H. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 58 (1992) 485-490
28. Ives N.J., Wheatley K., Stowe R.L., Krijnen P., Pluoin P.F., van Jaarsveld B.C., and Gray R. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 18 (2003) 298-304
29. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1998-2000. JAMA 290 (2003) 199-206